What is the current Avanos Medical, Inc. (AVNS) stock price?

Avanos Medical, Inc. is currently trading at $24.96, a change of -0.08% from the previous close. The 52-week range spans from $9.30 to $25.49.

Where can I buy Avanos Medical, Inc. stock?

You can buy Avanos Medical, Inc. (AVNS) at any regulated online broker. Compare the best options (Trade Republic, Scalable Capital, Interactive Brokers, DEGIRO) in our broker comparison by fees, savings plans, and available exchanges.

← Back to Screener

Sector: Healthcare

Open in Terminal → AVNSLive chart · Key metrics · News · Smart money

Avanos Medical, Inc.

AVNS Small Cap

Healthcare · Medical Devices

Updated: Jun 14, 2026, 22:19 UTC

$24.96

-0.08% today

52W: $9.30 – $25.49

52W Low: $9.30 Position: 96.7% 52W High: $25.49

🔗 Compare Brokers

Price Chart

Key Metrics

P/E Ratio

—

Price-to-Earnings

Forward P/E

19.97x

Forward Price/Earnings

P/S Ratio

1.63x

Price-to-Sales

EV/EBITDA

22.21x

Enterprise Value/EBITDA

Div. Yield

—

Annual dividend yield

Market Cap

$1.2B

Market Capitalization

Revenue Growth

8.8%

YoY Revenue Growth

Profit Margin

-10.39%

Net profit margin

ROE

-9.18%

Return on Equity

Beta

1.57

Market sensitivity

Short Interest

3.32%

% of float sold short

Avg. Volume

1,498,449

Average daily volume

Valuation Analysis

Signal

N/A

vs. S&P 500 avg P/E (24.7x)

Analyst Consensus

None

0 analysts

About the Company

Avanos Medical, Inc., a medical technology company, provides medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions. The company also provides non-opioid pain solutions, including surgical pain and recovery products, which comprise ON-Q and ambIT surgical pain pump, Game Ready cold, and compression therapy systems. In addition, it offers interventional pain solutions, which provide minimally invasive pain-relieving therapies, such as COOLIEF chronic pain products; and Trident and Esentec RFA radiofrequency ablation products to treat chronic pain conditions. The company mark

Sector: Healthcare Industry: Medical Devices Country: United States Employees: 2,287 Exchange: NYQ

Avanos Medical, Inc. Stock at a Glance

Avanos Medical, Inc. (AVNS) is currently trading at $24.96 with a market capitalization of $1.2B. The 52-week range spans from $9.30 to $25.49; the current price is 2.1% below the yearly high. Year-over-year revenue growth stands at +8.8%.

💰 Dividend

Avanos Medical, Inc. currently does not pay a dividend. The company typically reinvests its earnings into growth initiatives and product development.

Avanos Medical, Inc.: The Investment Case in Detail

Avanos Medical, Inc. (AVNS) operates in the Healthcare — specifically Medical Devices — and is headquartered in United States. Below is a structured read of the investment case built directly from the latest fundamentals, valuation multiples, analyst positioning and smart-money flows. Each section translates raw numbers into the investment logic they imply, so you can decide whether the risk/reward fits your portfolio.

The Bear Case

Net margins remain negative, meaning every euro of revenue is still producing losses — the path to profitability is the central question for shareholders.

What to Watch Next

The share is trading at 96.7% of its 52-week range — a break above the recent high opens technical upside, a failure here often invites profit-taking.